| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Biology and Genetics |
Department of Cell Biology, University of Massachusetts Medical School, Worcester, Massachusetts 01655 [H. D., D. H., F. A., Q. N., E. B., A. J. v. W., J. B. L., J. L. S., G. S. S.], and Molecular Biology Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10021 [A. K.]
The cyclin-dependent kinase (cdk) inhibitors are key regulators of cell cycle progression. p27 and p21 are members of the Cip/Kip family of cdk inhibitors and regulate cell growth by inactivating cell cycle stage-specific CDK-cyclin complexes. Because down-regulation of osteoprogenitor proliferation is a critical step for osteoblast differentiation, we investigated expression of p27 and p21 during development of the osteoblast phenotype in rat calvarial osteoblasts and in proliferating and growth-inhibited osteosarcoma ROS 17/2.8 cells. Expression of these proteins indicates that p21, which predominates in the growth period, is related to proliferation control. p27 levels are maximal postproliferatively, suggesting a role in the transition from cell proliferation to osteoblast differentiation. We directly examined the role of p27 during differentiation of osteoprogenitor cells derived from the bone marrow (BM) of p27-/- mice. BM cells from p27 null mice exhibited increased proliferative activity compared with BM cells from wild-type mice and formed an increased number and larger size of osteoblastic colonies, which further differentiated to the mineralization stage. Although p27-/- adherent marrow cells proliferate faster, they retain competency for differentiation, which may result, in part, from observed higher p21 levels compared with wild type. Histological studies of p27-/- bones also showed an increased cellularity in the marrow cavity compared with the p27+/+. The increased proliferation in bone does not lead to tumorigenesis, in contrast to observed adenomas in the null mice. Taken together, these findings indicate that p27 plays a key role in regulating osteoblast differentiation by controlling proliferation-related events in bone cells.
This article has been cited by other articles:
|
|
 |
|
  S.-F. Chang, T.-K. Chang, H.-H. Peng, Y.-T. Yeh, D.-Y. Lee, C.-R. Yeh, J. Zhou, C.-K. Cheng, C. A. Chang, and J.-J. Chiu BMP-4 Induction of Arrest and Differentiation of Osteoblast-Like Cells via p21CIP1 and p27KIP1 Regulation Mol. Endocrinol., November 1, 2009; 23(11): 1827 - 1838. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. M. Teplyuk, M. Galindo, V. I. Teplyuk, J. Pratap, D. W. Young, D. Lapointe, A. Javed, J. L. Stein, J. B. Lian, G. S. Stein, et al. Runx2 Regulates G Protein-coupled Signaling Pathways to Control Growth of Osteoblast Progenitors J. Biol. Chem., October 10, 2008; 283(41): 27585 - 27597. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Li, M. Q. Hassan, S. Volinia, A. J. van Wijnen, J. L. Stein, C. M. Croce, J. B. Lian, and G. S. Stein A microRNA signature for a BMP2-induced osteoblast lineage commitment program PNAS, September 16, 2008; 105(37): 13906 - 13911. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Lamour, C. Detry, C. Sanchez, Y. Henrotin, V. Castronovo, and A. Bellahcene Runx2- and Histone Deacetylase 3-mediated Repression Is Relieved in Differentiating Human Osteoblast Cells to Allow High Bone Sialoprotein Expression J. Biol. Chem., December 14, 2007; 282(50): 36240 - 36249. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. M. Fischer, S. Zheng, R. Fan, and J. A. Voynow Neutrophil elastase inhibition of cell cycle progression in airway epithelial cells in vitro is mediated by p27kip1 Am J Physiol Lung Cell Mol Physiol, September 1, 2007; 293(3): L762 - L768. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Yeh, J. P. Miller, T. Gaur, T. D. Capellini, J. Nikolich-Zugich, C. de la Hoz, L. Selleri, T. G. Bromage, A. J. van Wijnen, G. S. Stein, et al. Cooperation between p27 and p107 during Endochondral Ossification Suggests a Genetic Pathway Controlled by p27 and p130 Mol. Cell. Biol., July 15, 2007; 27(14): 5161 - 5171. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Paris, W.-H. Wang, M.-H. Shin, D. S. Franklin, and O. M. Andrisani Homeodomain Transcription Factor Phox2a, via Cyclic AMP-Mediated Activation, Induces p27Kip1 Transcription, Coordinating Neural Progenitor Cell Cycle Exit and Differentiation Mol. Cell. Biol., December 1, 2006; 26(23): 8826 - 8839. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. W. Lee, J. H. Suh, A Y. Kim, Y. S. Lee, S. Y. Park, and J. B. Kim Histone Deacetylase 1-Mediated Histone Modification Regulates Osteoblast Differentiation Mol. Endocrinol., October 1, 2006; 20(10): 2432 - 2443. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Guenou, K. Kaabeche, C. Dufour, H. Miraoui, and P. J. Marie Down-Regulation of Ubiquitin Ligase Cbl Induced by Twist Haploinsufficiency in Saethre-Chotzen Syndrome Results in Increased PI3K/Akt Signaling and Osteoblast Proliferation Am. J. Pathol., October 1, 2006; 169(4): 1303 - 1311. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Cho, J. H. Kim, S. H. Back, and S. K. Jang Polypyrimidine Tract-Binding Protein Enhances the Internal Ribosomal Entry Site-Dependent Translation of p27Kip1 mRNA and Modulates Transition from G1 to S Phase Mol. Cell. Biol., February 15, 2005; 25(4): 1283 - 1297. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Qin, X. Li, J.-K. Ko, and N. C. Partridge Parathyroid Hormone Uses Multiple Mechanisms to Arrest the Cell Cycle Progression of Osteoblastic Cells from G1 to S Phase J. Biol. Chem., January 28, 2005; 280(4): 3104 - 3111. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Thomas, S. A. Johnson, N. A. Sims, M. K. Trivett, J. L. Slavin, B. P. Rubin, P. Waring, G. A. McArthur, C. R. Walkley, A. J. Holloway, et al. Terminal osteoblast differentiation, mediated by runx2 and p27KIP1, is disrupted in osteosarcoma J. Cell Biol., December 6, 2004; 167(5): 925 - 934. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Sunters, D. P. Thomas, W. A. Yeudall, and A. E. Grigoriadis Accelerated Cell Cycle Progression in Osteoblasts Overexpressing the c-fos Proto-oncogene: INDUCTION OF CYCLIN A AND ENHANCED CDK2 ACTIVITY J. Biol. Chem., March 12, 2004; 279(11): 9882 - 9891. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Wang and M. J. Garabedian Modulation of Glucocorticoid Receptor Transcriptional Activation, Phosphorylation, and Growth Inhibition by p27Kip1 J. Biol. Chem., December 19, 2003; 278(51): 50897 - 50901. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Westendorf, S. K. Zaidi, J. E. Cascino, R. Kahler, A. J. van Wijnen, J. B. Lian, M. Yoshida, G. S. Stein, and X. Li Runx2 (Cbfa1, AML-3) Interacts with Histone Deacetylase 6 and Represses the p21CIP1/WAF1 Promoter Mol. Cell. Biol., November 15, 2002; 22(22): 7982 - 7992. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. K. Said, R. C. B. Moraes, U. Singh, F. S. Kittrell, and D. Medina Cyclin-dependent Kinase (cdk) Inhibitors/cdk4/cdk2 Complexes in Early Stages of Mouse Mammary Preneoplasia Cell Growth Differ., June 1, 2001; 12(6): 285 - 295. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Waltregny, I. Leav, S. Signoretti, P. Soung, D. Lin, F. Merk, J. Y. Adams, N. Bhattacharya, N. Cirenei, and M. Loda Androgen-Driven Prostate Epithelial Cell Proliferation and Differentiation in Vivo Involve the Regulation of p27 Mol. Endocrinol., May 1, 2001; 15(5): 765 - 782. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
